Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $18.7900 (-3.09%) ($18.7800 - $19.4500) on Mon. Dec. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.17% (three month average) | RSI | 82 | Latest Price | $18.7900(-3.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 4.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(50%) IWC(49%) XBI(49%) | Factors Impacting HALO price | HALO will decline at least -1.085% in a week (0% probabilities). VIXM(-38%) VXX(-20%) UUP(-7%) TLT(-3%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.085% (StdDev 2.17%) | Hourly BBV | 0 () | Intraday Trend | -3.2% | | | |
|
5 Day Moving Average | $19.32(-2.74%) | 10 Day Moving Average | $19.19(-2.08%) | 20 Day Moving Average | $18.24(3.02%) | To recent high | -3.8% | To recent low | 25.9% | Market Cap | $2.568b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |